Answer
Lomitapide mesylate has an elimination half-life of approximately 29 hours, reported following a radiolabelled oral solution dose in healthy subjects.
Sources for this answer
- Lojuxta 5mg hard capsulesChiesi Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 6Document updated
Sources checked